4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000007
CEO & President sold 5,513 shares at $16.82 ($92,729)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Sale : show line 1 in the form 10b5-1 | −5,513 | $16.82 | $92,729 | 351,994 | D |
| Open-market sales · 5,513 sh · avg $16.82 · $92,729 | ||||||
Loading xslF345X06/ownership.xml…